Healthcare provider profile · identity verified

Melissa B. Vourlitis, D.O.

Family Practice · BERKELEY, CA · NPI 1235236977

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	245	47
Atorvastatin Calcium	Atorvastatin Calcium	229	54
Gabapentin	Gabapentin	212	46
Quetiapine Fumarate	Quetiapine Fumarate	172	39
Sertraline Hcl	Sertraline Hcl	154	29
Donepezil Hcl	Donepezil Hcl	148	35
Furosemide	Furosemide	145	36
Trazodone Hcl	Trazodone Hcl	132	25
Amlodipine Besylate	Amlodipine Besylate	131	29
Eliquis	Apixaban	124	29
Pantoprazole Sodium	Pantoprazole Sodium	116	23
Escitalopram Oxalate	Escitalopram Oxalate	103	28
Lisinopril	Lisinopril	102	30
Potassium Chloride	Potassium Chloride	102	23
Memantine Hcl	Memantine Hcl	96	23
Metoprolol Succinate	Metoprolol Succinate	87	20
Mirtazapine	Mirtazapine	87	24
Metoprolol Tartrate	Metoprolol Tartrate	80	13
Tamsulosin Hcl	Tamsulosin Hcl	69	17
Duloxetine Hcl	Duloxetine Hcl	68	17
Losartan Potassium	Losartan Potassium	65	25
Alendronate Sodium	Alendronate Sodium	52	11
Risperidone	Risperidone	52	12
Bumetanide	Bumetanide	50	suppressed
Omeprazole	Omeprazole	50	11
Olanzapine	Olanzapine	47	suppressed
Carvedilol	Carvedilol	46	suppressed
Midodrine Hcl	Midodrine Hcl	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Methenamine Hippurate	Methenamine Hippurate	38	suppressed
Simvastatin	Simvastatin	38	11
Metformin Hcl	Metformin Hcl	37	11
Clopidogrel	Clopidogrel Bisulfate	35	13
Tramadol Hcl	Tramadol Hcl	34	15
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Spironolactone	Spironolactone	32	suppressed
Atenolol	Atenolol	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Famotidine	Famotidine	29	12
Montelukast Sodium	Montelukast Sodium	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	11
Xarelto	Rivaroxaban	29	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Latanoprost	Latanoprost	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Valproic Acid	Valproic Acid	20	suppressed
Digoxin	Digoxin	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Valsartan	Valsartan	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Finasteride	Finasteride	16	suppressed
Baclofen	Baclofen	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Lorazepam	Lorazepam	15	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Primidone	Primidone	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Lurasidone Hcl	Lurasidone Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error